Airway hyper-responsiveness and small airway function in children with well-controlled asthma

Jianfeng Huang1, Mingzhi Zhang1, Xiaobo Zhang1

  • 1Department of Respiratory, Children's Hospital of FuDan University, ShangHai, China.

Pediatric Research
|February 27, 2015
PubMed

Insights

Children with well-controlled asthma often have airway hyper-responsiveness (AHR) and impaired small airway function. Even in controlled asthma, reduced small airway function is linked to AHR.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Asthma Research

Background:

  • Airway hyper-responsiveness (AHR) and small airway function are crucial in pediatric asthma.
  • The role of small airways in well-controlled asthma with AHR remains unclear.

Purpose of the Study:

  • To assess AHR and small airway function in children with well-controlled asthma.
  • To explore the relationship between AHR and small airway function in this population.

Main Methods:

  • Compared 116 children with well-controlled asthma (Group A) to 46 healthy children (Group C).
  • Utilized spirometry, impulse oscillometry (IOS), and methacholine challenge tests (MCT).

Main Results:

  • No significant differences in FEV1 or FEV1/FVC ratio between groups.
  • Group A showed significantly lower FEF25-75 and X5 compared to controls.
  • 90.5% of Group A were positive to MCT, with lower FEF25-75 in those positive for AHR.

Conclusions:

  • AHR is prevalent in most children with well-controlled asthma.
  • Children with well-controlled asthma and AHR exhibit poorer small airway function compared to those without AHR.
Abstract

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
5.0K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.8K
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
2.1K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.3K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.4K